227 related articles for article (PubMed ID: 2901516)
1. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
[TBL] [Abstract][Full Text] [Related]
2. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
[TBL] [Abstract][Full Text] [Related]
3. Role of antibody dependent cell mediated cytotoxicity in ABO hemolytic disease of the newborn.
Patil JS; Gupte SC
Indian J Pediatr; 1995; 62(5):587-92. PubMed ID: 10829927
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
Whyte J; Graham H
Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
[TBL] [Abstract][Full Text] [Related]
5. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.
Ukita M; Takahashi A; Nunotani T; Kihana T; Watanabe S; Yamada N
Vox Sang; 1989; 56(3):181-6. PubMed ID: 2728395
[TBL] [Abstract][Full Text] [Related]
6. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
7. Complement is not activated in ABO-haemolytic disease of the newborn.
Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
[TBL] [Abstract][Full Text] [Related]
8. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
9. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
Li P; Pang LH; Liang HF; Chen HY; Fan XJ
Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
[TBL] [Abstract][Full Text] [Related]
10. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
11. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.
Romano EL; Rossi Devivo ML; Soyano A; Linares J
Clin Exp Immunol; 1984 Feb; 55(2):451-8. PubMed ID: 6538121
[TBL] [Abstract][Full Text] [Related]
12. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
Romano EL; Hughes-Jones NC; Mollison PL
Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
[TBL] [Abstract][Full Text] [Related]
13. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of ABO-haemolytic disease of the newborn.
Haque KM; Rahman M
Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease.
Das S; Shastry S; Chakravarthy PK; Baliga PB
Transfus Med; 2021 Feb; 31(1):30-35. PubMed ID: 32969542
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
17. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
18. Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population.
Han P; Kiruba R; Ong R; Joseph R; Tan KL; Wong HB
Aust Paediatr J; 1988 Feb; 24(1):35-8. PubMed ID: 3355442
[TBL] [Abstract][Full Text] [Related]
19. [The Correlation Analysis between the Titer of IgG Anti-A/B Erythrocyte Antibody In Vivo of the Neonate and the Severity of Hemolytic Disease of Newborn].
Song J; Yang T; Zhou XF; Yang YZ; Peng DL; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):547-551. PubMed ID: 35395995
[TBL] [Abstract][Full Text] [Related]
20. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.
Deb J; Jain A; Kaur D; Bahadur A; Basu S; Negi G
Transfus Apher Sci; 2024 Feb; 63(1):103864. PubMed ID: 38135544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
